ANT-GROUP/KOMINFO
24.5.2022 07:33:06 CEST | Business Wire | Press release
The Ministry of Communication and Informatics (“Kominfo”) today announced its partnership with fintech training platform 10x1000 Tech for Inclusion (“10x1000”) to recruit local talents to enroll in 10x1000’s “Flex” Fintech Foundation Program.
This partnership forms part of Kominfo’s Digital Entrepreneurship Academy (“DEA”) program, which aims to prepare and nurture talents to accelerate digital transformation in the field of entrepreneurship and to improve the digital economy, with a target of 60,000 people being trained in 2022.
“The Ministry of Communication and Informatics appreciates the collaboration with 10x1000 to carry out digital entrepreneurship training through the DEA program. The results of the program are expected to improve the quality of Micro, Small and Medium Enterprises (MSMEs) and promote the digital economy in Indonesia,” said Hary Budiarto, Head of HR & Research Agency, Ministry of Communication and Informatics (Kominfo).
With the vision to train 1,000 emerging talents and tech leaders each year for ten years, 10x1000 saw a total of 1,067 learners from 66 countries and regions complete its “Flex” Fintech Foundation Program and Fintech Leadership Program in 2021. Of which, more than 150 learners were from Indonesia, making the country the second largest globally in terms of learner intake.
“We are deeply encouraged by the overwhelming responses from Indonesia last year, and excited to partner with Kominfo to further expand the reach in Indonesia and make 'Flex' available to more local entrepreneurs and professionals to enhance their fintech mindset, knowledge and skills to better allow them to drive digital economic growth,” said Mr. Jason Pau, Program Lead of 10x1000. “Technology pervades nearly every aspect of our lives, and we hope this partnership will help Indonesia bridge its digital skills gap while empowering and improving the lives of local communities. Together with Kominfo and other local partners, we look forward to contributing more to Indonesia’s digital development goals.”
“The Coordinating Ministry of Human Development and Culture also expresses our appreciation to Kominfo for taking the initiative in driving such fintech training collaborations for women entrepreneurs and MSMEs (an initiative of the Ministry) with 10x1000,” said Femmy Eka Kartika Putri, Deputy of Coordination for Quality Improvement of Children, Women and Youth, Coordinating Ministry for Human Development and Culture (Kemenko PMK). “At least 60% of MSMEs in Indonesia are managed by women and contribute at least 61.07% of the country's GDP. With the 'Flex' Fintech Foundation Program by 10x1000 Tech for Inclusion, it will encourage women entrepreneurs to further enhance their businesses through digital technology. The training program is expected to help women entrepreneurs and MSMEs overcome challenges such as limited access to entrepreneurship and understanding of digital technology, as well as difficulties in obtaining access to capital.”
Registration for the “Flex” Fintech Foundation Program is now open through Kominfo’s Digital Entrepreneurship Academy website here . The first batch of training is slated to start on 6 June. Local fintech and banking associations will support the initiative by inviting their members to enroll the program as well, including the Indonesia Fintech Association (AFTECH), Indonesian Joint Funding Fintech Association (AFPI), Indonesian Sharia Fintech Association (AFSI), Indonesian Crowdfunding Service Association (ALUDI), Indonesian Blockchain Association (ABI), Association of Indonesia Shariah Banks (ASBISINDO), Indonesian Sharia Insurance Association (AASI), Association of National Commercial Banks (PERBANAS), and Indonesian E-commerce Association (idEA).
The partnership with Kominfo is the latest effort by 10x1000 to deepen its collaborations with partners worldwide. Globally, 10x1000 has forged partnerships with the IFC, United Nations Economic Commission for Africa, UN World Food Programme, SME Finance Forum Managed by the IFC, Dubai International Financial Centre, MDEC, KPMG and fintech associations from Hong Kong, Singapore, Malaysia, MENA, the Philippines and Thailand to recruit learners and grow the community.
About KOMINFO
Ministry of Communication and Informatics is responsible to carrying out government affairs in the field of communication and information technology to assist the President in administering government. Its main task and function to formulate national policies, implementation policies, and technical policies in the field of communication and informatics which include post, telecommunications, broadcasting, information and communication technology, multimedia services and information dissemination. The Ministry of Communications and Informatics is led by a Minister of Communication and Information (Menkominfo) who since October 23, 2019 has been held by Johnny Gerard Plate.
About DEA
The Digital Entrepreneurship Academy (DEA) is a program from the Ministry of Communication and Information that aims to prepare digital talent to accelerate Indonesia digital transformation in the field of digital entrepreneurship in order to improve the digital economy, with a target of 60,000 people being trained in 2022. The targets of this program include creating new digital entrepreneurs, upskilling advanced digital entrepreneurs, and developing digital entrepreneurship in inclusive villages. More details of the program please visit https://komin.fo/DEA
.
About 10x1000 Tech for Inclusion
10x1000 Tech for Inclusion is an open and global fintech training platform that enables learners to become drivers of digital economic growth. Its mission is to train 1,000 emerging talents and tech leaders each year for the next ten years. 10x1000 is a philanthropic initiative launched jointly by the International Finance Corporation (IFC), a member of the World Bank Group, and Alipay in 2018.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220523006072/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
